NCT01734109

Brief Summary

Negative-pressure wound therapy (NPWT) is an important adjunct for management of wounds, and promotes granulation tissue and angiogenesis. Despite these known means for facilitation of wound management, further research is needed to examine whether this modality is superior to other currently used options, thus defining clear indications for and benefits of NPWT. This would also help establish the role of combination therapy, using NPWT with simultaneous irrigation or other forms of dressings. This study aims to compare treatment efficacy of NPWT, NPWT plus proprietary simultaneous irrigation, and traditional hospital standard of care for treatment of grade III \& IV pressure ulcers. Primary endpoint of this study is comparison of reduction of wound volume between the three treatment arms; and secondary endpoints include bacterial load, rate of wound healing, preparation for grafting, and pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 27, 2012

Completed
4 days until next milestone

Study Start

First participant enrolled

December 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

November 28, 2012

Status Verified

November 1, 2012

Enrollment Period

9 months

First QC Date

November 21, 2012

Last Update Submit

November 27, 2012

Conditions

Keywords

Negative Pressure Wound TherapyIrrigation TherapyPressure UlcersSacral Ulcers

Outcome Measures

Primary Outcomes (1)

  • Comparison of reduction in wound volume between Quantum with Irrigation v Standard of Care

    Comparison of reduction in wound volume between Quantum with Irrigation versus standard of care over 12 weeks treatment period.

    12-weeks

Secondary Outcomes (1)

  • Comparison of reduction in wound volume between Quantum with Irrigation v Quantum without irrigation

    12 weeks

Other Outcomes (1)

  • Pain

    12 weeks

Study Arms (3)

Standard of Care - Wound Care

PLACEBO COMPARATOR

Standard, acceptable local wound care management, consisting of topical treatments, chemical debriders, or light bedside debridement.

Quantum NPWT

ACTIVE COMPARATOR

Intervention with Quantum NPWT to Standard III/IV pressure ulcers for 12 weeks.

Device: Quantum Negative Pressure Wound Therapy Device

Quantum NPWT with Irrigation

ACTIVE COMPARATOR

NPWT with the Quantum device, with the addition of simultaneous irrigation using 0.25% acetic acid.

Device: Quantum Negative Pressure Wound Therapy Device

Interventions

To compare the additional benefit of Quantum Negative pressure wound therapy device with and without simultaneous irrigation.

Also known as: Quantum NPWT
Quantum NPWTQuantum NPWT with Irrigation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Female between the ages of 18 and 70
  • Any patient with a stage III/IV pressure ulcer of the size large enough to indicate use of Negative Pressure Treatment.

You may not qualify if:

  • Clinical evidence of active, gross infection.
  • Patient or patient's guardian refuses consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Hospital System

Detroit, Michigan, 48202, United States

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Sandra J Berriman, Ph.D.

    Innovative Therapies, Inc.

    STUDY DIRECTOR
  • Kenneth Moquin, MD

    Henry Ford Hospital System

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kenneth Moquin, MD

CONTACT

Nadia Obeid, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2012

First Posted

November 27, 2012

Study Start

December 1, 2012

Primary Completion

September 1, 2013

Study Completion

March 1, 2014

Last Updated

November 28, 2012

Record last verified: 2012-11

Locations